RUNX2 and osteosarcoma: In osteosarcoma, CBX4 has been shown to enhance tumorigenesis by activating HIF1α signaling [24] and by recruiting the histone acetyltransferase general control nonderepressible 5 (GCN5) to upregulate runt-related transcription factor 2 (Runx2) [25].